Cytokinetics, Incorporated (CYTK) Social Stream



Cytokinetics, Incorporated (CYTK): $50.79

-0.76 (-1.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CYTK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

CYTOKINETICS INC (CYTK) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CYTK.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 8 $75 $40 $53.444 $54.52 -1.97%
2021-12-01 9 $75 $40 $53.5 $54.52 -1.87%
2021-12-10 10 $75 $40 $53.909 $54.52 -1.12%
2021-12-21 10 $75 $40 $54.545 $54.52 0.05%
2022-02-01 11 $75 $40 $54.666 $54.52 0.27%
2022-02-15 11 $75 $40 $54.5 $54.52 -0.04%
2022-02-28 11 $75 $40 $54.166 $54.52 -0.65%
2022-03-02 11 $75 $40 $53.916 $54.52 -1.11%
2022-04-13 11 $75 $40 $54.272 $54.52 -0.45%
2022-04-29 11 $75 $40 $54.636 $54.52 0.21%
2022-05-05 11 $75 $40 $55.636 $54.52 2.05%
2022-05-16 11 $75 $40 $57.545 $54.52 5.55%
2022-05-23 12 $80 $40 $60.916 $54.52 11.73%
2022-05-26 12 $80 $40 $59.5 $54.52 9.13%
2022-06-17 12 $80 $40 $61.333 $54.52 12.5%
2022-08-05 10 $80 $54 $64.545 $54.52 18.39%
2022-08-09 10 $80 $56 $65.636 $54.52 20.39%
2022-08-12 10 $80 $15 $61.545 $54.52 12.89%
2022-09-02 10 $80 $15 $62.727 $54.52 15.05%

The Trend in the Analyst Price Target


Over the past 19 months, CYTK's average price target has gone up $35.73.

Over the past 43 weeks, CYTK's average upside potential has been 43.59%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-21 10 75 40 54.545 40.83 33.59%
2022-01-09 11 75 40 54.666 35.15 55.52%
2022-03-02 11 75 40 54.272 37.63 44.23%
2022-05-23 12 80 40 60.916 39.85 52.86%
2022-06-10 12 80 40 61.333 39.50 55.27%

CYTK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.15 8 2 0 0 0 10

The Trend in the Broker Recommendations


Over the past 48 weeks, CYTK's average broker recommendation rating improved by 0.8.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, CYTOKINETICS INC's upside potential (average analyst target price relative to current price) is greater than 350.32% of them.
  • In terms of how CYTOKINETICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 1906.74% of that group.
  • In the context of Pharmaceutical Products stocks, CYTOKINETICS INC's average analyst price target is greater than 1714.24% of them.
  • CYTK has a lower variance in analysts' estimates than -1516.61% of stocks in the mid market cap category.

Stocks similar to CYTOKINETICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CYRX, CORT, and CMRX.

Is CYTK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6153 seconds.